Ozempic
Semaglutide · 0.5–2 mg/week
Novo Nordisk
GLP-1 receptor agonist — stimulates insulin secretion, suppresses glucagon, slows gastric emptying.
FDA Approved
December 2017
Last Updated
March 2026
Sources
5 peer-reviewed
Standard
YMYL / E-E-A-T
Medically reviewed by Dr. Sarah Mitchell, MD (Board-Certified Obesity Medicine) · Editorial Policy
How Ozempic Works
GLP-1 receptor agonist — stimulates insulin secretion, suppresses glucagon, slows gastric emptying.
Key Pharmacological Actions
- • Appetite suppression via GLP-1 receptors in the hypothalamus and brainstem
- • Delayed gastric emptying, extending the feeling of fullness after meals
- • Reduced "food noise" — the constant preoccupation with food
- • Improved insulin sensitivity independent of weight loss
- • Glucose-dependent insulin secretion, reducing hypoglycemia risk
Dosing & Administration
Titration Guidance
Ozempic uses a gradual dose escalation schedule over 4–8 weeks to maintenance dose. Starting at 0.25 mg/week allows your body to adjust and minimizes GI side effects. Do not skip doses or increase faster than your physician recommends — this increases the risk of nausea, vomiting, and diarrhea. If side effects are severe at any dose, your doctor may extend the time at that dose before increasing.
Clinical Trial Results
SUSTAIN-6
201626% reduction in MACE (CV events) in T2DM high-risk patients
SELECT
202320% CV risk reduction in non-diabetic overweight/obese patients
Average Weight Loss: In clinical trials, patients taking Ozempic lost an average of 10–14% of their body weight. Individual results vary significantly — some patients lose considerably more or less than the average. Response depends on factors including baseline weight, diet, exercise, dose tolerated, and individual biology.
Side Effects
The most common side effects of Ozempic are gastrointestinal. They typically peak during dose escalation and improve over time as your body adjusts.
Contraindications
- • Personal/family history of MTC
- • MEN2 syndrome
- • Pregnancy
This is not a complete list of side effects. Serious but rare side effects include pancreatitis, gallbladder disease, and allergic reactions. If you experience severe abdominal pain, signs of allergic reaction, or any concerning symptoms, contact your healthcare provider immediately. Consult the full FDA prescribing information for a comprehensive list.
Cost & Insurance Coverage
Coverage Information
- • Commercial Insurance: Many plans cover Ozempic with prior authorization. Requirements typically include documentation of type 2 diabetes diagnosis and, in some cases, documented failure of lifestyle modification.
- • Medicare Part D: Most Part D plans cover Ozempic for type 2 diabetes with standard formulary restrictions.
- • Manufacturer Savings: Novo Nordisk offers savings cards that can significantly reduce out-of-pocket costs for eligible commercially insured patients.
Eligibility Criteria
Pros & Cons
Advantages
- ✓Longest safety track record of any GLP-1 (since 2017)
- ✓Once weekly dosing
- ✓Strong cardiovascular data (SUSTAIN, SELECT)
- ✓Often better insurance coverage than Wegovy
Limitations
- ✗Not FDA-approved for obesity (off-label only)
- ✗Lower dose than Wegovy — less weight loss
- ✗Requires physician willing to prescribe off-label
- ✗GI side effects
Frequently Asked Questions
Quick Facts
Ozempic — From Our Blog
Medically reviewed articles to help you understand Ozempic (Semaglutide).
Ozempic vs Wegovy: Which GLP-1 is Right for You?
Both Ozempic and Wegovy contain semaglutide, but they're approved for different uses. Understand the key differences in dosing, cost, and insurance coverage.
Wegovy vs. Ozempic in 2026: Same Molecule, Very Different Drugs
Both drugs contain semaglutide. Both are made by Novo Nordisk. Yet Wegovy and Ozempic have different FDA indications, dosing ceilings, insurance pathways, and clinical profiles. Here's the complete breakdown.
Ozempic and PCOS: The Weight Loss Connection, Real Patient Outcomes, and What the Research Shows
PCOS affects 1 in 10 women and makes weight loss exceptionally difficult. Here's what the research says about semaglutide for PCOS patients.
Medical Disclaimer
This page provides general information about this medication for educational purposes only. It does not constitute medical advice and should not be used as a substitute for consultation with your healthcare provider. Always consult your physician or pharmacist before starting, changing, or stopping any medication. Drug pricing, insurance coverage, and clinical data may change after publication.